BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Hypothalamus
,
Avian flu virus
,
Ciprofibrate
,
rs7903146
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
activation of MAPK activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Differential response of arsenic stress in two varieties of Brassica juncea L.
Colon in acute intestinal infection.
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through …
Ethanol-induced mitogen activated protein kinase activity mediated through protein kinase C.
Influence of aging and calorie restriction on MAPKs activity in rat kidney.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harbo…
p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ER…
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adults
Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ